Mf. Duggankeen et al., IMMUNOGENETIC FACTORS IN HPV-ASSOCIATED CERVICAL-CANCER - INFLUENCE ON DISEASE PROGRESSION, European journal of immunogenetics, 23(4), 1996, pp. 275-284
No HLA allele or specificity was significantly different in frequency
between a group of 150 cervical cancer patients from north-west Englan
d and controls (corrected P values). HLA-DRB11501/DQB1*0602 was non-s
ignificantly increased, particularly among patients with HPV16-positiv
e tumours. HLA-B7-positive patients had a significantly poorer clinica
l outcome than HLA-B7-negative patients. A significant component of th
e genotypic effect is down-regulation of HLA-B7 expression by the tumo
ur cells.